Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
SOLENO THERAPEUTICS INC (SLNO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/12/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/11/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/10/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/06/2023 SC 13G JANUS HENDERSON GROUP PLC reports a 10.1% stake in SOLENO THERAPEUTICS, INC.
10/05/2023 SC 13G RA CAPITAL MANAGEMENT, L.P. reports a 4.6% stake in SOLENO THERAPEUTICS, INC.
10/04/2023 D Form D - Notice of Exempt Offering of Securities:
10/03/2023 SC 13D/A Carlyle Group Inc. reports a 10% stake in Soleno Therapeutics, Inc.
09/29/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/28/2023 SC 13D/A PERCEPTIVE ADVISORS LLC reports a 23.7% stake in Soleno Therapeutics, Inc.
09/28/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
09/28/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
09/27/2023 S-3MEF Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
09/27/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/27/2023 8-K Termination of a Material Definitive Agreement, Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/18/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"REDWOOD CITY, Calif"
08/15/2023 SC 13D/A PERCEPTIVE ADVISORS LLC reports a 22.1% stake in Soleno Therapeutics, Inc.
08/08/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Soleno Therapeutics, Inc. Condensed Consolidated Balance Sheets"
08/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/28/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
07/21/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
07/10/2023 8-K Investor presentation
Docs: "Presentation Materials"
06/06/2023 SC 13D/A PERCEPTIVE ADVISORS LLC reports a 27% stake in Soleno Thereputics, Inc.
06/02/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/01/2023 SC 13D Vivo Opportunity Fund Holdings, L.P. reports a 50.8% stake in Soleno Therapeutics, Inc.
05/26/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/26/2023 SC 13D/A SCHULER JACK W reports a 5% stake in Soleno Therapeutics, Inc.
05/25/2023 SC 13D/A PERCEPTIVE ADVISORS LLC reports a 23.8% stake in Soleno Thereputics, Inc.
05/18/2023 SC 13D PERCEPTIVE ADVISORS LLC reports a 22.8% stake in Soleno Thereputics, Inc.
05/15/2023 SC 13G Vivo Opportunity Fund Holdings, L.P. reports a 20% stake in Soleno Therapeutics, Inc.
05/10/2023 SC 13D/A Carlyle Group Inc. has filed a Schedule 13D for Soleno Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy